Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SULT4A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | KMT2B | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | HECA | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | FBN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | NUTM2E | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | SPNS3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | PHF7 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | CHRNB2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |